APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 159-167

  Chen, Qi ^a   Reis, Steven E ^b   Kammerer, Candace M ^a   McNamara, Dennis M ^b   Holubkov, Richard ^c   Sharaf, Barry L ^d   Sopko, George ^e   Pauly, Daniel F ^f   Bairey Merz, C Noel ^g   Kamboh, M Ilyas ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Apolipoproteins; Coronary disease; Risk factors

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEX RATIO; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 0038306152     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00160-6     Document Type: Article

References (35)

1. Mahley R.W., Innerarity T.L., Rall S.C. Jr, Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25:1984;1277-1294.
2. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res. 33:1992;447-454.
3. Beisiegel U., Weber W., Ihrke G., Herz J., Stanley K.K. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341:1989;162-164.
4. Mahley R.W., Angelin B. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv. Intern. Med. 29:1984;385-411.
5. Scuteri A., Bos A.J., Zonderman A.B., Brant L.J., Lakatta E.G., Fleg J.L. Is the apoE4 allele an independent predictor of coronary events? Am. J. Med. 110:2001;28-32.
6. Breslow J.L. Genetic basis of lipoprotein disorders. J. Clin. Invest. 84:1989;373-380.
7. Luc G., Bard J.M., Arveiler D., Evans A., Cambou J.P., Bingham A., Amouyel P., Schaffer P., Ruidavets J.B., Cambien F., et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler. Thromb. 14:1994;1412-1419.
8. Wilson P.W., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., Schaefer E.J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. J. Am. Med. Assoc. 272:1994;1666-1671.
9. Wang X.L., McCredie R.M., Wilcken D.E. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler. Thromb. Vasc. Biol. 15:1995;1030-1034.
10. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:1995;4725-4727.
11. Merz C.N., Kelsey S.F., Pepine C.J., Reichek N., Reis S.E., Rogers W.J., Sharaf B.L., Sopko G. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J. Am. Coll. Cardiol. 33:1999;1453-1461.
12. Bittner V., Olson M., Kelsey S.F., Rogers W.J., Bairey Merz C.N., Armstrong K., Reis S.E., Boyette A., Sopko G. Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators. Am. J. Cardiol. 85:2000;1083-1088.
13. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
14. Lipid Research Clinics Program. The Manual of Laboratory Operations. Lipid and Lipoprotein Analysis. Bethesda, MD: National Institute of Health, 1974.
15. Kamboh M.I., Aston C.E., Hamman R.F. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 112:1995;145-159.
16. Newman S. Biostatistical methods in epidemiology. 2001;115-117 Wiley, New York.
17. Shaw L.J., Miller D.D., Romeis J.C., Kargl D., Younis L.T., Chaitman B.R. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann. Intern. Med. 120:1994;559-566.
18. Schaefer E.J., Lamon-Fava S., Johnson S., Ordovas J.M., Schaefer M.M., Castelli W.P., Wilson P.W. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler. Thromb. 14:1994;1105-1113.
19. Assmann G., Schmitz G., Menzel H.J., Schulte H. Apolipoprotein E polymorphism and hyperlipidemia. Clin. Chem. 30:1984;641-643.
20. Kamboh M.I., Sepehrnia B., Ferrell R.E. Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. Dis. Markers. 7:1989;49-55.
21. Srinivasan S.R., Ehnholm C., Wattigney W., Berenson G.S. Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: the Bogalusa Heart Study. Metabolism. 42:1993;381-386.
22. Eichner J.E., Kuller L.H., Ferrell R.E., Kamboh M.I. Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet. Epidemiol. 6:1989;493-499.
23. Sanghera D.K., Ferrell R.E., Aston C.E., McAllister A.E., Kamboh M.I., Kimm S.Y. Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9-10-year-old girls. Atherosclerosis. 126:1996;35-42.
24. Ou T., Yamakawa-Kobayashi K., Arinami T., Amemiya H., Fujiwara H., Kawata K., Saito M., Kikuchi S., Noguchi Y., Sugishita Y., Hamaguchi H. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis. 137:1998;23-28.
25. Wilson P.W., Schaefer E.J., Larson M.G., Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler. Thromb. Vasc. Biol. 16:1996;1250-1255.
26. Lahoz C., Schaefer E.J., Cupples L.A., Wilson P.W., Levy D., Osgood D., Parpos S., Pedro-Botet J., Daly J.A., Ordovas J.M. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis. 154:2001;529-537.
27. Hixson J.E. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler. Thromb. 11:1991;1237-1244.
28. Humphries S.E., Talmud P.J., Hawe E., Bolla M., Day I.N., Miller G.J. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet. 358:2001;115-119.
29. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
30. Parthasarathy S., Steinberg D., Witztum J.L. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:1992;219-225.
31. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis. 98:1993;1-9.
32. Hayek T., Oiknine J., Brook J.G., Aviram M. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem. Biophys. Res. Commun. 201:1994;1567-1574.
33. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:1987;5928-5931.
34. Williams R.J., Motteram J.M., Sharp C.H., Gallagher P.J. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis. 94:1992;153-159.
35. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14:1996;55-61.